Selected research
Industry Growth & Trends
Global Softgel CDMO Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Softgel CDMO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Softgel CDMO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Softgel CDMO market include Procaps, Patheon, NextPharma, Lonza, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics and Siegfried, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Softgel CDMO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Softgel CDMO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Softgel CDMO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Softgel CDMO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Softgel CDMO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Softgel CDMO Market by Company
Procaps
Patheon
NextPharma
Lonza
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
Catalent
Aenova
Sirio Pharma
Softgel CDMO Segment by Type
Pharmaceutical Softgel CDMO
Nutraceutical Softgel CDMO
Others
Softgel CDMO Segment by Application
Pharmaceutical Company
Biotechnology Company
Others
Softgel CDMO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Softgel CDMO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Softgel CDMO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Softgel CDMO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Softgel CDMO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Softgel CDMO
- Nutraceutical Softgel CDMO
- Others
Applications
- Pharmaceutical Company
- Biotechnology Company
- Others
Companies covered
- Procaps
- Patheon
- NextPharma
- Lonza
- Samsung Biologics
- Fareva
- WuXi AppTech
- WuXi Biologics
- Siegfried
- Catalent
- Aenova
- Sirio Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Softgel CDMO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Softgel CDMO Market Size by Region (2021-2032)
- 1.4.1 Global Softgel CDMO Market Size by Region (2021-2026)
- 1.4.2 Global Softgel CDMO Market Size by Region (2027-2032)
- 1.5 Key Regions Softgel CDMO Market Size (2021-2032)
- 1.5.1 North America Softgel CDMO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Softgel CDMO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Softgel CDMO Market Size Growth Rate (2021-2032)
- 1.5.4 South America Softgel CDMO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Softgel CDMO Market Size Growth Rate (2021-2032)
2 Softgel CDMO Market by Type
- 2.1 Type Introduction
- 2.1.1 Pharmaceutical Softgel CDMO
- 2.1.2 Nutraceutical Softgel CDMO
- 2.1.3 Others
- 2.2 Global Softgel CDMO Market Size by Type
- 2.2.1 Global Softgel CDMO Market Size Overview by Type (2021-2032)
- 2.2.2 Global Softgel CDMO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Softgel CDMO Market Size Forecasted by Type (2027-2032)
- 2.3 Global Softgel CDMO Market Size by Regions
- 2.3.1 North America Softgel CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Softgel CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Softgel CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Softgel CDMO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Softgel CDMO Market Size Breakdown by Type (2021-2026)
3 Softgel CDMO Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Company
- 3.1.2 Biotechnology Company
- 3.1.3 Others
- 3.2 Global Softgel CDMO Market Size by Application
- 3.2.1 Global Softgel CDMO Market Size Overview by Application (2021-2032)
- 3.2.2 Global Softgel CDMO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Softgel CDMO Market Size Forecasted by Application (2027-2032)
- 3.3 Global Softgel CDMO Market Size by Regions
- 3.3.1 North America Softgel CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Softgel CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Softgel CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Softgel CDMO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Softgel CDMO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Softgel CDMO Industry Trends
- 4.2 Softgel CDMO Industry Drivers
- 4.3 Softgel CDMO Industry Opportunities and Challenges
- 4.4 Softgel CDMO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Softgel CDMO Revenue (2021-2026)
- 5.2 Global Softgel CDMO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Softgel CDMO Key Company Headquarters & Area Served
- 5.4 Global Softgel CDMO Company, Product Type & Application
- 5.5 Global Softgel CDMO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Softgel CDMO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Softgel CDMO Players Market Share by Revenue in 2025
- 5.6.3 2025 Softgel CDMO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Procaps
- 6.1.1 Procaps Company Information
- 6.1.2 Procaps Business Overview
- 6.1.3 Procaps Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Procaps Softgel CDMO Product Portfolio
- 6.1.5 Procaps Recent Developments
- 6.2 Patheon
- 6.2.1 Patheon Company Information
- 6.2.2 Patheon Business Overview
- 6.2.3 Patheon Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Patheon Softgel CDMO Product Portfolio
- 6.2.5 Patheon Recent Developments
- 6.3 NextPharma
- 6.3.1 NextPharma Company Information
- 6.3.2 NextPharma Business Overview
- 6.3.3 NextPharma Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 NextPharma Softgel CDMO Product Portfolio
- 6.3.5 NextPharma Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lonza Softgel CDMO Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 Samsung Biologics
- 6.5.1 Samsung Biologics Company Information
- 6.5.2 Samsung Biologics Business Overview
- 6.5.3 Samsung Biologics Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Samsung Biologics Softgel CDMO Product Portfolio
- 6.5.5 Samsung Biologics Recent Developments
- 6.6 Fareva
- 6.6.1 Fareva Company Information
- 6.6.2 Fareva Business Overview
- 6.6.3 Fareva Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Fareva Softgel CDMO Product Portfolio
- 6.6.5 Fareva Recent Developments
- 6.7 WuXi AppTech
- 6.7.1 WuXi AppTech Company Information
- 6.7.2 WuXi AppTech Business Overview
- 6.7.3 WuXi AppTech Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 WuXi AppTech Softgel CDMO Product Portfolio
- 6.7.5 WuXi AppTech Recent Developments
- 6.8 WuXi Biologics
- 6.8.1 WuXi Biologics Company Information
- 6.8.2 WuXi Biologics Business Overview
- 6.8.3 WuXi Biologics Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 WuXi Biologics Softgel CDMO Product Portfolio
- 6.8.5 WuXi Biologics Recent Developments
- 6.9 Siegfried
- 6.9.1 Siegfried Company Information
- 6.9.2 Siegfried Business Overview
- 6.9.3 Siegfried Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Siegfried Softgel CDMO Product Portfolio
- 6.9.5 Siegfried Recent Developments
- 6.10 Catalent
- 6.10.1 Catalent Company Information
- 6.10.2 Catalent Business Overview
- 6.10.3 Catalent Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Catalent Softgel CDMO Product Portfolio
- 6.10.5 Catalent Recent Developments
- 6.11 Aenova
- 6.11.1 Aenova Company Information
- 6.11.2 Aenova Business Overview
- 6.11.3 Aenova Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Aenova Softgel CDMO Product Portfolio
- 6.11.5 Aenova Recent Developments
- 6.12 Sirio Pharma
- 6.12.1 Sirio Pharma Company Information
- 6.12.2 Sirio Pharma Business Overview
- 6.12.3 Sirio Pharma Softgel CDMO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Sirio Pharma Softgel CDMO Product Portfolio
- 6.12.5 Sirio Pharma Recent Developments
7 North America
- 7.1 North America Softgel CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Softgel CDMO Market Size by Country (2021-2026)
- 7.3 North America Softgel CDMO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Softgel CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Softgel CDMO Market Size by Country (2021-2026)
- 8.3 Europe Softgel CDMO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Softgel CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Softgel CDMO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Softgel CDMO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Softgel CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Softgel CDMO Market Size by Country (2021-2026)
- 10.3 South America Softgel CDMO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Softgel CDMO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Softgel CDMO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Softgel CDMO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst